Plasma homocysteine and cognitive decline in older hypertensive subjects. (Q51009758)

27 March 2018

title

Plasma homocysteine and cognitive decline in older hypertensive subjects. (English)

1 reference

27 March 2018

author

Sunil K. Narayan

1

1 reference

27 March 2018

Brian K Saxby

2

1 reference

27 March 2018

Michael J. Firbank

3

1 reference

27 March 2018

John T. O'Brien

4

1 reference

27 March 2018

0 references

8

Gerard Stansby

1 reference

27 March 2018

author name string

Frances Harrington

5

1 reference

27 March 2018

Ian G McKeith

6

1 reference

27 March 2018

Monica Hansrani

7

1 reference

27 March 2018

Gary A Ford

9

1 reference

27 March 2018

publication date

6 May 2011

1 reference

27 March 2018

International Psychogeriatrics

published in

1 reference

27 March 2018

volume

23

1 reference

27 March 2018

issue

10

1 reference

27 March 2018

page(s)

1607-1615

1 reference

27 March 2018

Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Homocysteine and cognitive performance in the Framingham offspring study: age is important

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Hyperhomocysteinemia and Alzheimer's disease: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

The central nervous system in animal models of hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Homocysteine and cognitive function in a population-based study of older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Effects of hypertension on attention, memory, and executive function in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Effect of antihypertensive treatment with candesartan or amlodipine on glutathione and its redox status, homocysteine and vitamin concentrations in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Homocysteine and cognition--no longer a hypothesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Vitamins B(12), B(6), and folic acid for cognition in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

The cognitive drug research computerized assessment system for demented patients: A validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

7 January 2021

Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

7 January 2021

Validity of the Trail Making Test as an Indicator of Organic Brain Damage

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

7 January 2021

Low vitamin B-12 status and risk of cognitive decline in older adults.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

7 January 2021

Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal Ageing Study.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

7 January 2021

Study on COgnition and Prognosis in the Elderly (SCOPE).

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000779

7 January 2021

10.1017/S1041610211000779

Identifiers

DOI

1 reference

27 March 2018

PubMed ID

21554791

1 reference

27 March 2018